Brian Austin Green and Sharna Burgess celebrated the Global Gaming League launch event hosted by T-Pain and Clinton Sparks, ...

Eli Lilly's biggest catalyst at the moment comes from its hit weight loss medications, Mounjaro and Zepbound. Lilly is investing billions of dollars to scale manufacturing efforts as demand for ...

Pink and Carey Hart are the proud parents of one daughter and one son Pink and Carey Hart have the cutest family of four. The pop star and the motocross racer have been married for nearly two ...

90 Day Fiance: The Other Way Season 6 star Lily has confirmed what Josh revealed earlier this week: They are no longer together and are headed for divorce. Lily shared the news on TikTok in an ...

Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the ...

Ethan Slater’s ex-wife, Dr. Lilly Jay, is speaking out about her divorce from the Wicked star. In a personal essay for The Cut, Lilly wrote, “No one gets married thinking they’ll get ...

There’s more to a bathing suit than meets the eye . . . and there’s more to beachdressing this season than a bathing suit.

Meghan Markle doesn’t often wear pink, but for her friend Samantha Stone’s baby shower, Meghan pulled out a full-length gown in the hue to celebrate. Kelly McKee Zajfen shared a photo of her ...

Wicked' star Ethan Slater filed for divorce from his wife of five years, Lilly Jay, shortly after his romance with Ariana Grande went public Theo Wargo/Getty Before his relationship with Ariana ...

Lily Allen claimed she never had sex “not drunk” before her husband, David Harbour. “I don’t think I’d ever had sex with anybody not drunk before I got together with him. So, that was di ...

Alicia Brunker is a writer who covers celebrity, royal, and fashion news for InStyle.com. She joined InStyle's digital team in 2017, and previously contributed to ELLE, T: The New York Times Style ...

Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In a study sponsored by Lilly ...